SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-582065
Filing Date
2016-05-06
Accepted
2016-05-06 16:31:52
Documents
38
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d119969d10q.htm 10-Q 206206
2 EXHIBIT 31.1 d119969dex311.htm EX-31.1 6377
3 EXHIBIT 31.2 d119969dex312.htm EX-31.2 6353
4 EXHIBIT 32.1 d119969dex321.htm EX-32.1 4658
  Complete submission text file 0001193125-16-582065.txt   1507085

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxgn-20160331.xml EX-101.INS 248212
6 XBRL TAXONOMY EXTENSION SCHEMA oxgn-20160331.xsd EX-101.SCH 21584
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxgn-20160331_cal.xml EX-101.CAL 24117
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxgn-20160331_def.xml EX-101.DEF 45149
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxgn-20160331_lab.xml EX-101.LAB 182006
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxgn-20160331_pre.xml EX-101.PRE 117845
Mailing Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SOUTH SAN FRANCISCO CA 94080 650-635-7000
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 161628550
SIC: 2836 Biological Products, (No Diagnostic Substances)